This study investigated the change in outcomes over 10-years in patients with stage 3 colon cancer who received FOLFOX chemotherapy. Researchers suggested that this treatment improved the outcomes of these patients.

This study investigated the effects of physical activity (PA) and long-term fatigue (tiredness) in patients with colorectal cancer. Researchers suggested that PA after the diagnosis is associated with less tiredness in these patients.

This study compared the effectiveness and safety of bevacizumab biosimilar (BE1040V) to the reference drug (Avastin) in the treatment of patients with metastatic colorectal cancer (mCRC). Researchers suggested that the effectiveness and safety of the biosimilar were similar to the reference drug bevacizumab.

This study investigated the effectiveness of the combined treatment with cytokine-induced killer cell (CIKC) immunotherapy and chemotherapy after surgery in colorectal cancer. Researchers suggested that this therapy improves treatment outcomes in patients with colorectal cancer.

This study investigated the survival outcomes of patients who underwent surgery for colorectal cancer (CRC) metastasis (spread to other parts of the body). Researchers suggested that metastasis surgery is associated with survival improvement in these patients.

This study investigated the effectiveness of robotic-assisted liver surgery (RALS) compared to laparoscopic liver surgery (LLS) in advanced colorectal cancer. Researchers suggested that RALS is similarly safe and effective as LLS for these patients.

This study investigated the effect of chemotherapy on the survival of patients with stage 2 and 3 mucinous colorectal cancer (mucCRC). Researchers suggested that chemotherapy improved the survival of these patients.

This study investigated the effectiveness of radiation therapy (RT) after surgery in patients with T4 (cancer that has grown outside of the colon outer layer and invades the surrounding tissues) colon cancer. Researchers suggested that RT improved overall survival in these patients.

This study investigated the factors predictive of a permanent stoma (PS; an opening in the body that allows waste to exit) in patients with rectal cancer. Researchers suggested that tumor distance from the anus was associated with PS in these patients.

This study investigated the association between vitamin D blood levels and survival outcomes in patients with metastatic colorectal cancer (mCRC). Researchers suggested that higher levels of vitamin D in the blood were associated with better survival.